Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
NCT00000570
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
NIH
Sponsor class
Conditions
Lung Diseases
Respiratory Distress Syndrome
Interventions
DRUG:
pulmonary surfactant
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)